Pharmaceuticals · PSX stock comparison

AGP vs GlaxoSmithKline (GLAXO)

AGP Limited and GlaxoSmithKline Pakistan Limited: compare valuation, dividends and financial performance side by side.

AGP ↗

AGP Limited

Rs 153.52

PSX snapshot · 18/11/2026, 17:13:00 PKT

GLAXO ↗

GlaxoSmithKline Pakistan Limited

Rs 333.13

PSX snapshot · 18/11/2026, 17:13:00 PKT

Gross and net marginsROE and ROAInventory and liquidity
AGP vs GlaxoSmithKline (GLAXO): share price, valuation and financial ratios
MetricAGPGLAXO
Market & valuationPSX quotes; issuer filings and dated SCSTrade fundamentals
Share priceRs 153.52Rs 333.13
P/E (TTM)24.03×9.66×
Annual dividend yield5.21%FY 20255.10%FY 2025
Annual dividend per shareRs 8.00FY 2025Rs 17.00FY 2025
Price / book (calculated)3.62×2026 Q23.08×2026 Q2
Market capRs 42.99BRs 106.09B
1-year price change · excluding payouts-16.46%-14.20%
Profitability & financial healthIssuer filings / SCSTrade · period and source shown per figure
Book value per shareRs 42.392026 Q2Rs 108.122026 Q2
Return on equity (ROE)18.27%2025 Q429.77%2025 Q4
Return on assets (ROA)11.55%2025 Q419.78%2025 Q4
Gross profit margin48.62%2025 Q437.00%2025 Q4
Net profit margin11.49%2025 Q415.21%2025 Q4
Inventory turnover4.71×2025 Q45.16×2025 Q4
Current ratio0.92×2026 Q22.28×2026 Q2
Quick ratio0.41×2025 Q41.48×2025 Q4

Sources & reporting periods

Prices and trailing P/E: PSX DPS. Annual yield = full-year cash dividend divided by displayed PSX price. Annual dividends and financial ratios: reviewed issuer filings and SCSTrade. Financial year and dividend/share are shown for both stocks; unclear feed yields are excluded. Price/book uses reported book value. PSX 1-year price changes exclude payouts; they are not total returns. Reviewed issuer ratios use unconsolidated statements and labelled year-end denominators. Unverified borrowing ratios are omitted.

AGP · PSX ↗/Financials ↗Basis not specified
GLAXO · PSX ↗/Financials ↗Basis not specified

More pharmaceuticals comparisons

Pharmaceuticals

Pharmaceutical companies: compare profitability, returns and working capital.